Among them, the activation of the STAT3 signaling pathway by IL-6 increases the number of CRC initiating cells, which can induce non-tumor stem cells to express stem cell markers and increase tumorigenic capacity in vivo [42]. The gene discussed is IL6; the disease is neoplasm.